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High-throughput screening (HTS) of enzymatic activity is important for directed evolution-based enzyme
engineering. However, substrate and product diffusion can severely compromise these HTS assays. In
this issue of Chemistry & Biology, Kintses and coworkers describe a microfluidic platform for the directed
evolution of enzymes in droplets that allows for the screening of 107 mutants per round of evolution.Directed protein evolution approaches
have proven to be highly valuable for the
study of the structure, function, and
evolution of proteins, as well as for obtain-
ing improved proteins for biotechnolog-
ical or industrial applications (Romero
and Arnold, 2009). The wide variety of ex-
isting proteins or newly computationally
designed proteins that exhibit low binding
affinity or catalytic efficiency can serve as
the starting point for the directed evolu-
tion process (Fleishman and Baker,
2012). One of the main steps in any
directed evolution experiment is the
screening of amutant library for enhanced
binding or catalytic activity. Screening
assays used for the analysis of large
mutant libraries should be highly efficient,
sensitive enough to detect even weak
activities, and provide a large dynamic
range to enable the detection of mutants
with even small improvements in activity
(Yang and Withers, 2009). Typically,
high-throughput screening (HTS) tech-
niques are able to enrich libraries contain-
ing 106–1013 mutants for clones possess-
ing improved activity. This strategy for
library enrichment of protein binders is
a well established and robust process
that relies on different protein display
technologies (e.g., phage, bacterial, or
yeast display), followed by selection on
the basis of target ligand binding (Levin
and Weiss, 2006). This platform thus
maintains linkage between genotype
(i.e., the gene that can be replicated) and
phenotype (i.e., the activity of the mutant
protein) by virtue of the physical binding
of the displayed mutant protein to its
ligand. When designing HTS for the study
of enzyme catalysis, however, establish-
ing such linkage can be challenging due
to diffusion of substrate or product.Several solutions for the substrate/
product diffusion problem were devel-
oped over the last decade in an effort to
overcome the inherent difficulty in em-
ploying HTS for the study of enzyme
catalysis. The trapping of a positively
charged fluorescent product on the nega-
tively charged bacterial cell surface facili-
tated screening for enhanced hydrolytic
activity of proteases displayed on the
cell surface. This elegant approach was
used to screen for protease mutants
with enhanced catalytic activity and was
further developed to generate mutants
with novel substrate specificities (Vara-
darajan et al., 2005). Another approach
to directly detect the activity of glycosyl-
transferases expressed in the cytoplasm
of Escherichia coli relies on the selective
trapping of fluorescently-labeled product
within the bacterial cells (Aharoni et al.,
2006; Yang and Withers, 2009). Both
approaches have proven to be highly
efficient for HTS of large mutant libraries
via fluorescence-activated cell sorting
(FACS). However, the main limitations of
these approaches are the requirement
for a specific design and the synthesis of
appropriate substrates, thus rendering
their application to a wide variety of
enzymes problematic.
A significant advance in assay design
for HTS application came with the devel-
opment of in vitro compartmentalization
technologies (IVC). These technologies,
pioneered by Tawfik and Griffiths, enable
the compartmentalization of genes into
aqueous microdroplets dispersed in
water-in-oil emulsions (Tawfik and Grif-
fiths, 1998). Themaintenance of the geno-
type-phenotype linkage in this system is
achieved by the co-compartmentalization
of single genes, the substrate for theChemistry & Biology 19, August 24, 2012enzymatic reaction being studied, and
an in vitro transcription/translation solu-
tion for protein expression. In this set-
up, the product must be linked to the
genes themselves so as to enable the re-
covery of active clones, rendering the
detection of multiple turn-over events
problematic. To improve the IVC ap-
proach for the HTS of enzyme libraries,
an additional emulsification step was
implemented to generate double water-
in-oil-in-water emulsions amenable for
FACS analysis. The use of flow cytometry
to directly sort fluorescent droplets pro-
vided the high dynamic range needed for
the detection of enzyme activity and, in
principle, allows for the use of a wide
variety of existing fluorescent substrates.
However, despite the success of this
approach for HTS of PON1 and Ebg
libraries (Aharoni et al., 2005; Mastrobat-
tista et al., 2005), the usefulness of this
approach for screening other enzyme
activities proved to be difficult, mainly
due to heterogeneity in droplet size. The
two emulsification steps required for
generating double emulsions leads to
relatively large variation in droplet size.
Such variablity can dramatically affect
the enzyme, substrate and product
concentrations trappedwithin the droplet,
which greatly reduces the accuracy of the
optical readout of the assay. Previously,
such a limitation was overcome by the
addition of internal marker to the droplets
that significantly complicated the experi-
ment (Aharoni et al., 2005; Mastrobattista
et al., 2005). In the paper by Kintses
et al. (2012), appearing in this issue of
Chemistry & Biology, an elegant solution
to this problem is proposed using micro-
fluidic devices to generate highly uniform
mono-disperse droplets.ª2012 Elsevier Ltd All rights reserved 929
Figure 1. Schematic Representation of Directed Evolution in Microfluidic Devices
E. coli cells expressing the enzyme mutant library (red) are co-compartmentalized with lysis buffer and non-fluorescent substrate (blue). Upon droplet formation,
the cells are lysed, and the enzyme reaction takes place within the droplet, leading to the accumulation of fluorescent product. Droplets exhibiting the highest
fluorescence are sorted and plasmids are extracted and introduced into fresh E. coli cells to complete the directed evolution cycle.
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PreviewsIn recent years, several steps of
the typical directed evolution process
have been incorporated into microfluidic
devices, including library generation
and screening (Kintses et al., 2010). It
has been shown that droplets generated
by microfluidic device are extremely
uniform and are suitable for the encap-
sulation of single cells or for in vitro
expression of single genes (Kintses
et al., 2010). Due to the uniformity of these
droplets, they can be used for quantitative
assays, leading to a reduction of many
orders of magnitude in the reaction
volumes required, relative to those
employed in microtiter plate assays.
Another advantage of this technology
is the ability to control the timing of the
initiation of an enzymatic reaction, allow-
ing it to occur before fluorescence-
based sorting of the droplets. Previous
work by Agresti et al. (2010) employed
a similar approach to co-compartmen-
talize yeast cells expressing horseradish
peroxidase (HRP) on the cell surface,
together with its non-fluorescent sub-
strate. Following incubation, droplets
containing active mutants were sorted
according to the level of the oxidized
and fluorescent product that accumulates
in the droplets. Using this system, Agresti
et al. (2010) succeeded in increasing
the catalytic efficiency of HRP 10-fold,
highlighting the possibility of using yeast
surface display in conjunction with930 Chemistry & Biology 19, August 24, 2012microfluidic technologies for enzyme
engineering.
As reported in this issue of Chemistry &
Biology, Kintses et al. (2012) have now
managed to integrate a complete directed
evolution experiment, including single
cell compartmentalization, screening for
enzymatic activity, and recovery of im-
proved mutants using microfluidic
devices. The target of their study was
the arylsulfatase from Pseudomonas
aeruginosa (PAS), an enzyme able to
hydrolyze a diverse range of substrates,
including arylsulfate, arylphsophates,
and phsophonates with varying efficien-
cies. Using microfluidic devices, Kintses
et al. (2012) succeeded in co-compart-
mentalizing 107 E. coli cells expressing
PAS mutants in their cytoplasm together
with a phosphonate substrate and lysis
reagents (Figure 1). Following droplet
incubation to enable the accumulation of
fluorescent product, the droplets were
sorted for enrichment of active PAS
mutants. Next, plasmids from these
clones were extracted and electroporated
into fresh E. coli cells to enable microtiter
plate screening of single mutants for the
identification of improved clones. The ex-
tracted plasmids were also used as DNA
templates for the generation of new
libraries to facilitate additional round of
directed evolution. This strategy allowed
for the isolation of mutants with modest,
yet significant, increases in activity andª2012 Elsevier Ltd All rights reservedexpression that could not be identified
by conventional screening efforts using
microtiter plate assays.
Kintses et al. (2012) improved two
important steps in the HTS assay for
enzymatic activity that are essential in
many directed evolution experiments.
First, they have generated highly uniform
droplets in contrast to the large variations
in droplet size produced by conventional
approaches, which allow for the estab-
lishment of a sensitive and reproducible
screening assay. Second, they developed
a protocol enabling cell lysis in the drop-
lets, which allows the use of a wide variety
of fluorescent substrates, regardless of
their ability to penetrate the E. coli cell
membrane. This feature is of particular
importance, because most microtiter-
based enzyme screening assays involve
cell lysis prior to kinetic analysis.
Overall, this research highlights the
power of microfluidic devices in conjunc-
tion with in vitro compartmentalization for
performing directed evolution experi-
ments. A significant challenge facing
future studies will be to simplify the sys-
tem, therebyallowing the large community
of protein engineers to adopt suchdevices
for the study of diverse target enzymes.
Another challenge is to utilize the system
to achieve improvements in various
enzyme properties, including an alteration
of substrate specificities and improve-
ments in stability. Future applications of
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include functional genomics and the
screening of genomic libraries for the
discovery of new enzymatic activities.
Such approaches will likely lead to better
exploitation of the immense potential in-
herent in the engineering of existing and
newly discovered enzymes for research
and biotechnological applications.
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Peptides perform a wide number of physiological roles as signaling molecules between cells as well as other
functions. The detection of peptides has generally relied on one of two distinct techniques: immunohisto-
chemistry and mass spectrometry. In this issue of Chemistry & Biology, Neupert and colleagues describe
an approach to combine these techniques.Peptides represent the largest group of
intercellular signaling molecules (Strand,
2003; Fricker, 2012). Well known exam-
ples include insulin (a peptide hormone)
and enkephalin (a neuropeptide). Hun-
dreds of distinct endogenous peptides
have been identified over the past
century, with recent advances in mass
spectrometry adding many additional
peptides in the past decade. Physiolog-
ical processes known to be controlled
by peptides include feeding and body
weight regulation, water intake, fertility,
arousal and sleep/wake cycles, thermo-
regulation, memory, pain, anxiety, and
depression (Strand, 2003; Fricker, 2012).
In addition to their role in cell-cell commu-
nication, peptides have been proposed to
play roles in intracellular signaling (Ferro
et al., 2004; Fricker, 2010).
Neuropeptides are produced from
precursor proteins by selective enzymesthat cleave the protein at specific sites
(Fricker, 2012). A number of examples
are known in which the precursor is
cleaved into different products depending
on the cell type, and these products have
distinct functions (Figure 1). For example,
the peptide adrenocorticotropic hormone
is the major product of its precursor in
mammalian anterior pituitary. While in
the intermediate pituitary, this peptide is
further cleaved into two smaller peptides:
alpha-melanocyte-stimulating hormone
and corticotropin-like intermediate lobe
peptide (Eipper et al., 1986). The different
sets of peptides derived from the same
precursor produce distinct physiological
effects, largely through binding to recep-
tors that are selective for either the larger
or smaller forms of each peptide. In
another example, the 31 amino acid-long
form of beta-endorphin is an agonist at
the mu opioid receptor, whereas the 27residue peptide is an antagonist at this
receptor (Hammonds et al., 1984). Thus,
in order to fully understand the function
of a neuron, it is not enough to know
what neuropeptide precursor the cell
expresses—it is necessary to know the
precise forms of peptides produced
within that neuron.
For decades, the major technique to
detect neuropeptides in individual cells
required antibodies to the peptide. Immu-
nohistochemical staining is very useful for
the localization of peptides to specific
cells in tissues. However, most antibodies
are not highly specific for just one form of
a peptide and often cross react with N-
and/or C-terminally extended peptides.
Furthermore, antibodies require prior
knowledge of the peptide and cannot be
used to detect novel peptides. Mass
spectrometry-based techniques have
emerged as powerful tools to characterizeª2012 Elsevier Ltd All rights reserved 931
